How to speed up weight loss on Wegovy: what the evidence says

What the STEP 1 trial tells us about who loses more

The STEP 1 trial enrolled over 1,900 adults with obesity or overweight plus a weight-related condition. On 2.4mg semaglutide weekly, average body-weight loss was around 15% at 68 weeks. But averages can be misleading. Participants who combined treatment with consistent lifestyle support (reduced-calorie eating and structured physical activity) tended to sit towards the higher end of that range. The trial was designed this way deliberately: all participants received lifestyle counselling, reflecting the licensed indication, which pairs Wegovy with a reduced-calorie diet and increased physical activity. That pairing is not a footnote; it is part of how the medicine is designed to work, as the NHS semaglutide medicines page makes clear.

One misconception worth setting down: Wegovy does not require you to be hungry or miserable to produce results. The medicine suppresses appetite meaningfully at therapeutic doses, which means most people naturally eat less without dramatic restriction. The practical job is to make the food you do eat count, enough protein, enough fibre, not so much processed food that you override the satiety signal.

If you are earlier in your journey and wondering what the first few weeks typically look like, the week 1 experience on Wegovy is worth reading before drawing conclusions about your own response.

The role of protein, activity and muscle during semaglutide treatment

Rapid weight loss of any kind carries a risk of losing lean muscle alongside fat. Muscle tissue is metabolically active, losing it slows the rate at which your body burns energy at rest, which works against long-term results. This is a well-documented pattern in weight-loss research, and it applies to GLP-1 treatment as much as to calorie restriction alone.

Two things counter it. First, adequate protein: aiming for roughly 1.2–1.6 g per kilogram of body weight daily is a widely cited range in nutrition research, though personal targets should be agreed with a healthcare professional or dietitian. On Wegovy, when overall food volume falls, protein tends to get crowded out unless you actively prioritise it, high-protein sources like eggs, fish, legumes and Greek yoghurt are a practical starting point. Second, resistance exercise: strength training two to three times a week signals to the body to hold onto muscle even in a calorie deficit. Cardio contributes to overall energy balance but does not preserve muscle in the same way.

Sleep matters more than most people expect. Poor sleep elevates ghrelin (a hunger hormone) and cortisol, which can blunt the appetite-suppressing effect of semaglutide. Alcohol is worth flagging too: it is calorie-dense, disrupts sleep architecture and can lower the inhibitions that make mindful eating easier.

For a fuller picture of what typical progress looks like month to month, the guide on weight loss results on Wegovy covers the evidence in detail.

Titration, patience and when to talk to your prescriber

A question our prescribers hear regularly: "I'm not losing much yet, is something wrong?" Often, the answer is simply timing. The dose titration schedule for Wegovy starts at 0.25mg and steps up roughly every four weeks toward the 2.4mg maintenance dose. If you want to understand how long before weight loss on Wegovy typically begins, it helps to know that the starter doses exist so your digestive system adjusts gradually and are not at the therapeutic level where most meaningful weight loss occurs. Expecting rapid results before reaching maintenance dose sets up unnecessary frustration.

If progress stalls at a maintenance dose, that is a different conversation. Plateaus are physiologically normal, the body adapts to a new lower weight and reduces energy expenditure accordingly. Some people find that revisiting their eating pattern, adding or changing their exercise, or addressing sleep helps move things again. Others find that an honest review with their prescriber is the most useful step, particularly if side effects have been limiting how consistently they can take the medicine.

The page on not losing weight on Wegovy covers the common reasons progress stalls and what can be done about each one. And if you are wondering about the broader timeline, how long weight loss on Wegovy typically takes sets realistic expectations backed by trial data.

For context on how Wegovy compares as a treatment option within the wider landscape of weight management medicines, the weight loss treatments overview is a useful starting point. If you are considering beginning or continuing semaglutide through a regulated UK pharmacy, how to access Wegovy in the UK explains the prescription route and what to look for in a provider.

Wegovy is available on private prescription through a GPhC-registered pharmacy following clinical assessment. If you would like a prescriber to review your situation and advise on your treatment plan, speak to our prescribers through a free consultation.